Home › Funds › Logos Global Management LP › ERAS
Logos Global Management LP position in ERAS
ERASCA INC · Health Care
Logos Global Management LP reported holding 12,150,000 shares of ERAS (ERASCA INC) in its Q2 2026 13F filing — a position valued at US$222.6M, representing 9.58% of its reported portfolio and ranking #1 among its reported holdings. Logos Global Management LP has disclosed ERAS holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Logos Global Management LP's ERAS position evolved
Logos Global Management LP first disclosed a stake in ERAS in Q2 2024 at 5,900,000 shares (US$13.9M). The position peaked in Q2 2026 at 12,150,000 shares, worth US$222.6M. Across 9 filings, Logos Global Management LP increased the stake 6 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 12,150,000 shares valued at US$222.6M — an increase of 1,000,000 shares quarter over quarter.. Notable position changes include a 85% increase in Q3 2024 (shares fell 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 5.90M | $13.92M | New |
| Q3 2024 | 10.90M | $29.76M | Add |
| Q4 2024 | 12.50M | $31.38M | Add |
| Q1 2025 | 13.00M | $17.81M | Add |
| Q2 2025 | 15.00M | $19.05M | Add |
| Q3 2025 | 15.15M | $33.03M | Add |
| Q4 2025 | 13.00M | $48.36M | Reduce |
| Q1 2026 | 11.15M | $180.41M | Reduce |
| Q2 2026 | 12.15M | $222.59M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ERAS and 13F data
ERAS (ERASCA INC) is a Health Care company. 78 other funds we track also report a position in ERAS — the largest reported positions include Frazier Life Sciences Management, L.P. (US$457.5M), RTW INVESTMENTS, LP (US$328.8M), Venrock Adviser, LLC (US$327.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ERAS
- Frazier Life Sciences Management, L.P. 24.98M sh · $457.55M · Q2 2026
- RTW INVESTMENTS, LP 17.95M sh · $328.78M · Q2 2026
- Venrock Adviser, LLC 17.89M sh · $327.78M · Q2 2026
- Siren, L.L.C. 11.40M sh · $208.81M · Q2 2026
- Paradigm Biocapital Advisors LP 9.55M sh · $174.96M · Q2 2026
- ARCH Venture Management, LLC 7.09M sh · $129.92M · Q2 2026
- Cormorant Asset Management, LP 6.00M sh · $109.92M · Q2 2026
- Affinity Asset Advisors, LLC 5.25M sh · $96.18M · Q2 2026
- Vivo Capital, LLC 4.13M sh · $75.61M · Q2 2026
- a16z Capital Management, L.L.C. 2.86M sh · $52.44M · Q2 2026
- Soleus Capital Management, L.P. 2.70M sh · $49.46M · Q2 2026
- SAMLYN CAPITAL, LLC 2.26M sh · $41.35M · Q2 2026
More on Logos Global Management LP
FAQ
How long has Logos Global Management LP held ERAS?
Logos Global Management LP has disclosed ERAS holdings in 9 of the last 9 reported quarters, going back to Q2 2024.
What is Logos Global Management LP's current position in ERAS?
As of Q2 2026, Logos Global Management LP holds 12.15M shares of ERAS (ERASCA INC), valued at $222.59M, representing 9.58% of its reported portfolio and ranking #1.
Has Logos Global Management LP been buying or selling ERAS?
In the latest 13F filing (Q2 2026), Logos Global Management LP increased its position in ERAS. The position peaked in Q2 2026 at 12.15M shares.
Which other funds hold ERAS?
Other major institutional holders of ERAS include Frazier Life Sciences Management, L.P., RTW INVESTMENTS, LP, Venrock Adviser, LLC, among 78 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.